Cholangiocarcinoma discoveries and treatment approaches

Cholangiocarcinoma remains a surgical disease, but even with a successful resection the recurrence rate is about 70%. Rory L. Smoot, M.D., surgical oncologist at Mayo Clinic’s campus in Rochester, Minnesota, is an expert on cholangiocarcinoma and other biliary tract cancers. Hear Dr. Smoot discuss the systemic treatments and next-generation sequencing done at Mayo Clinic to extend patients’ lives while even more treatment discoveries are being made.


August 27, 2021

Created by

Mayo Clinic

Related Presenters

Rory Smoot, MD

Rory Smoot, MD

Hepatobiliary and Pancreas Surgeon
Surgical Oncologist

View full profile